IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma

Molecular Oncology

Volumn 10, Issue 6, 2016, Pages 895-909

  Peng, Hsuan Yu ^a,e   Jiang, Shih Sheng ^a   Hsiao, Jenn Ren ^b   Hsiao, Michael ^c   Hsu, Yuan Ming ^a   Wu, Guan Hsun ^a   Chang, Wei Min ^a,d   Chang, Jang Yang ^a,b   Jin, Shiow Lian Catherine ^e   Shiah, Shine Gwo ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

IL 8; Invasion; MicroRNA; Oral squamous cell carcinoma; SOCS2

Indexed keywords

ANTAGOMIR; GELATINASE A; GELATINASE B; INTERLEUKIN 8; MICRORNA; MICRORNA 424 5P; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; UNCLASSIFIED DRUG; MIRN424 MICRORNA, HUMAN; SOCS2 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUTH; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; MICRORNAS; MOUTH; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84962110871     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2016.03.001     Document Type: Article

References (63)

1. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., Fakhry C., Xie T.X., Zhang J., Wang J., Zhang N., El-Naggar A.K., Jasser S.A., Weinstein J.N., Trevino L., Drummond J.A., Muzny D.M., Wu Y., Wood L.D., Hruban R.H., Westra W.H., Koch W.M., Califano J.A., Gibbs R.A., Sidransky D., Vogelstein B., Velculescu V.E., Papadopoulos N., Wheeler D.A., Kinzler K.W., Myers J.N. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Ahomadegbe J.C., Barrois M., Fogel S., Le Bihan M.L., Douc-Rasy S., Duvillard P., Armand J.P., Riou G. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995, 10:1217-1227.
3. Benekli M., Baer M.R., Baumann H., Wetzler M. Signal transducer and activator of transcription proteins in leukemias. Blood 2003, 101:2940-2954.
4. Britschgi A., Andraos R., Brinkhaus H., Klebba I., Romanet V., Muller U., Murakami M., Radimerski T., Bentires-Alj M. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. Cancer cell 2012, 22:796-811.
5. Calin G.A., Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006, 66:7390-7394.
6. Callender T., el-Naggar A.K., Lee M.S., Frankenthaler R., Luna M.A., Batsakis J.G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994, 74:152-158.
7. Chen Z., Malhotra P.S., Thomas G.R., Ondrey F.G., Duffey D.C., Smith C.W., Enamorado I., Yeh N.T., Kroog G.S., Rudy S., McCullagh L., Mousa S., Quezado M., Herscher L.L., Van Waes C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res. 1999, 5:1369-1379.
8. Collins A.S., McCoy C.E., Lloyd A.T., O'Farrelly C., Stevenson N.J. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling. PloS One 2013, 8:e69090.
9. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., Alexander W.S. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4:540-545.
10. Croker B.A., Kiu H., Nicholson S.E. SOCS regulation of the JAK/STAT signalling pathway. Semin. Cel. Dev. Biol. 2008, 19:414-422.
11. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
12. Donnem T., Fenton C.G., Lonvik K., Berg T., Eklo K., Andersen S., Stenvold H., Al-Shibli K., Al-Saad S., Bremnes R.M., Busund L.T. MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PloS One 2012, 7:e29671.
13. Farabegoli F., Ceccarelli C., Santini D., Taffurelli M. Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma. J. Clin. Pathol. 2005, 58:1046-1050.
14. Fiegl H., Gattringer C., Widschwendter A., Schneitter A., Ramoni A., Sarlay D., Gaugg I., Goebel G., Muller H.M., Mueller-Holzner E., Marth C., Widschwendter M. Methylated DNA collected by tampons - a new tool to detect endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13:882-888.
15. Forastiere A., Koch W., Trotti A., Sidransky D. Head and neck cancer. New Engl. J. Med. 2001, 345:1890-1900.
16. Grandis J.R., Drenning S.D., Chakraborty A., Zhou M.Y., Zeng Q., Pitt A.S., Tweardy D.J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Invest. 1998, 102:1385-1392.
17. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., Kim J.D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4227-4232.
18. Gutzman J.H., Rugowski D.E., Nikolai S.E., Schuler L.A. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene 2007, 26:6341-6348.
19. Hu G., Zhou R., Liu J., Gong A.Y., Chen X.M. MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection. J. Infect. Dis. 2010, 202:125-135.
20. Huang C., Li H., Wu W., Jiang T., Qiu Z. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1. Oncol. Rep. 2013, 30:1223-1230.
21. Iglesias-Gato D., Chuan Y.C., Wikstrom P., Augsten S., Jiang N., Niu Y., Seipel A., Danneman D., Vermeij M., Fernandez-Perez L., Jenster G., Egevad L., Norstedt G., Flores-Morales A. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer. Carcinogenesis 2014, 35:24-33.
22. Inagaki-Ohara K., Kondo T., Ito M., Yoshimura A. SOCS, inflammation, and cancer. JAKSTAT 2013, 2:e24053.
23. Inui M., Martello G., Piccolo S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cel. Biol. 2010, 11:252-263.
24. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 2007, 57:43-66.
25. Jerjes W., Upile T., Petrie A., Riskalla A., Hamdoon Z., Vourvachis M., Karavidas K., Jay A., Sandison A., Thomas G.J., Kalavrezos N., Hopper C. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2010, 2:9.
26. Jiang S., Zhang H.W., Lu M.H., He X.H., Li Y., Gu H., Liu M.F., Wang E.D. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010, 70:3119-3127.
27. Klausen P., Pedersen L., Jurlander J., Baumann H. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 2000, 19:3675-3683.
28. Leong P.L., Xi S., Drenning S.D., Dyer K.F., Wentzel A.L., Lerner E.C., Smithgall T.E., Grandis J.R. Differential function of STAT5 isoforms in head and neck cancer growth control. Oncogene 2002, 21:2846-2853.
29. Letellier E., Schmitz M., Baig K., Beaume N., Schwartz C., Frasquilho S., Antunes L., Marcon N., Nazarov P.V., Vallar L., Even J., Haan S. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br. J. Cancer 2014, 111:726-735.
30. Li Q., Qiu X.M., Li Q.H., Wang X.Y., Li L., Xu M., Dong M., Xiao Y.B. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. Oncol. Rep. 2015, 33:2354-2360.
31. Liu S., Ren S., Howell P., Fodstad O., Riker A.I. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res. 2008, 21:545-558.
32. Lui V.W., Hedberg M.L., Li H., Vangara B.S., Pendleton K., Zeng Y., Lu Y., Zhang Q., Du Y., Gilbert B.R., Freilino M., Sauerwein S., Peyser N.D., Xiao D., Diergaarde B., Wang L., Chiosea S., Seethala R., Johnson J.T., Kim S., Duvvuri U., Ferris R.L., Romkes M., Nukui T., Kwok-Shing Ng P., Garraway L.A., Hammerman P.S., Mills G.B., Grandis J.R. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013, 3:761-769.
33. Manna S.K., Ramesh G.T. Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway. J. Biol. Chem. 2005, 280:7010-7021.
34. Maxwell S.A., Sacks P.G., Gutterman J.U., Gallick G.E. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck. Cancer Res. 1989, 49:1130-1137.
35. Mishima K., Yamada E., Masui K., Shimokawara T., Takayama K., Sugimura M., Ichijima K. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod. Pathol. 1998, 11:886-891.
36. Newton V.A., Ramocki N.M., Scull B.P., Simmons J.G., McNaughton K., Lund P.K. Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation. Am. J. Pathol. 2010, 176:2320-2332.
37. Nishioka C., Ikezoe T., Yang J., Nobumoto A., Kataoka S., Tsuda M., Udaka K., Yokoyama A. CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells. Int. J. Cancer 2014, 134:55-64.
38. Palmer D.C., Restifo N.P. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol. 2009, 30:592-602.
39. Park Y.T., Jeong J.Y., Lee M.J., Kim K.I., Kim T.H., Kwon Y.D., Lee C., Kim O.J., An H.J. MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J. Ovarian Res. 2013, 6:18.
40. Quentmeier H., Geffers R., Jost E., Macleod R.A., Nagel S., Rohrs S., Romani J., Scherr M., Zaborski M., Drexler H.G. SOCS2: inhibitor of JAK2V617F-mediated signal transduction. Leukemia 2008, 22:2169-2175.
41. Rokavec M., Oner M.G., Li H., Jackstadt R., Jiang L., Lodygin D., Kaller M., Horst D., Ziegler P.K., Schwitalla S., Slotta-Huspenina J., Bader F.G., Greten F.R., Hermeking H. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest. 2014, 124:1853-1867.
42. Rossa C., Sommer G., Spolidorio L.C., Rosenzweig S.A., Watson D.K., Kirkwood K.L. Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion. PloS One 2012, 7:e45197.
43. Ru P., Steele R., Hsueh E.C., Ray R.B. Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer 2011, 2:720-727.
44. Sato B.L., Sugawara A., Ward M.A., Collier A.C. Single blastomere removal from murine embryos is associated with activation of matrix metalloproteinases and Janus kinase/signal transducers and activators of transcription pathways of placental inflammation. Mol. Hum. Reprod. 2014, 20:1247-1257.
45. Shiah S.G., Hsiao J.R., Chang W.M., Chen Y.W., Jin Y.T., Wong T.Y., Huang J.S., Tsai S.T., Hsu Y.M., Chou S.T., Yen Y.C., Jiang S.S., Shieh Y.S., Chang I.S., Hsiao M., Chang J.Y. Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b. Cancer Res. 2014, 74:7560-7572.
46. Siavash H., Nikitakis N.G., Sauk J.J. Signal transducers and activators of transcription: insights into the molecular basis of oral cancer. Crit. Rev. Oral Biol. Med. 2004, 15:298-307.
47. Song J.I., Grandis J.R. STAT signaling in head and neck cancer. Oncogene 2000, 19:2489-2495.
48. St John M.A., Li Y., Zhou X., Denny P., Ho C.M., Montemagno C., Shi W., Qi F., Wu B., Sinha U., Jordan R., Wolinsky L., Park N.H., Liu H., Abemayor E., Wong D.T. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2004, 130:929-935.
49. Sutherland K.D., Lindeman G.J., Choong D.Y., Wittlin S., Brentzell L., Phillips W., Campbell I.G., Visvader J.E. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 2004, 23:7726-7733.
50. Tamiya T., Kashiwagi I., Takahashi R., Yasukawa H., Yoshimura A. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler. Thromb. Vasc. Biol. 2011, 31:980-985.
51. Trengove M.C., Ward A.C. SOCS proteins in development and disease. Am. J. Clin. Exp. Immunol. 2013, 2:1-29.
52. Vidal O.M., Merino R., Rico-Bautista E., Fernandez-Perez L., Chia D.J., Woelfle J., Ono M., Lenhard B., Norstedt G., Rotwein P., Flores-Morales A. In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol. Endocrinol. 2007, 21:293-311.
53. Vlotides G., Sorensen A.S., Kopp F., Zitzmann K., Cengic N., Brand S., Zachoval R., Auernhammer C.J. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem. Biophys. Res. Commun. 2004, 320:1007-1014.
54. Watanabe H., Iwase M., Ohashi M., Nagumo M. Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol. 2002, 38:670-679.
55. Wu K., Hu G., He X., Zhou P., Li J., He B., Sun W. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Pathol. Oncol. Res. 2013, 19:739-748.
56. Xia Z., Baer M.R., Block A.W., Baumann H., Wetzler M. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res. 1998, 58:3173-3180.
57. Xu J., Li Y., Wang F., Wang X., Cheng B., Ye F., Xie X., Zhou C., Lu W. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 2013, 32:976-987.
58. Yang H.L., Sun C., Sun C., Qi R.L. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte. Mol. Biol. Rep. 2012, 39:9113-9122.
59. Yen Y.C., Shiah S.G., Chu H.C., Hsu Y.M., Hsiao J.R., Chang J.Y., Huang W.C., Liao C.T., Cheng A.J., Lu Y.C., Chen Y.W. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol. Cancer 2014, 13:6.
60. Zhang M.Y., Fung T.K., Chen F.Y., Chim C.S. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm. J. Cell. Mol. Med. 2013, 17:1282-1290.
61. Zhang P., Li F., Li N., Zhu Q., Yang C., Han Q., Chen J., Lv Y., Yu L., Wei P., Liu Z. Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection. Hum. Immunol. 2014, 75:709-714.
62. Zhou R., Gong A.Y., Chen D., Miller R.E., Eischeid A.N., Chen X.M. Histone deacetylases and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells in response to microbial challenge by suppressing miR-424 and miR-503. PloS One 2013, 8:e65153.
63. Zhuang G., Wu X., Jiang Z., Kasman I., Yao J., Guan Y., Oeh J., Modrusan Z., Bais C., Sampath D., Ferrara N. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 2012, 31:3513-3523.